FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel pharmaceutic applications of compounds acting as mGluR5 antagonist, for treatment, prevention and/or delay of progressing of disorders of gastrointestinal tract, urinary tract and/or post-operation disorders, as well as for treatment, prevention and/or delay of progressing of pain associated with said disorders.
EFFECT: said purpose is realised.
10 cl
| Title | Year | Author | Number |
|---|---|---|---|
| ACETYLENE DERIVATIVES, METHOD OF THEIR OBTANING, PHARMACEUTICAL COMPOSITION BASED ON THEM AND THEIR USE AS ANTAGONISTS OF METABOTHROPIC GLUTAMATE RECEPTORS (MGLUR5) | 2002 |
|
RU2341515C2 |
| COMBINATIONS CONTAINING mGluR MODULATORS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2496494C2 |
| METABOTROPIC GLUTAMATE RECEPTOR MODULATORS FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2508107C2 |
| ARYLETHINYL DERIVATIVES | 2011 |
|
RU2573560C2 |
| PHARMACEUTICAL PREPARATION | 1994 |
|
RU2146522C1 |
| METHOD OF PRODUCING LACTONES | 0 |
|
SU749364A3 |
| TETRAHYDROPYRANE DERIVATIVES FOR NEUROLOGICAL DISEASES | 2011 |
|
RU2554344C2 |
| USING SUBSTITUTED 6-DIMETHYLAMINOMETHYL-1-PHENYLHEXANE COMPOUNDS IN ENURESIS THERAPY | 2001 |
|
RU2279875C2 |
| ANTAGONISTS OF ENDOTHELIAL RECEPTORS, PHARMACEUTICAL COMPOSITION, METHOD OF SYNTHESIS, METHOD OF INHIBITION OF ENDOTHELIAL RECEPTORS | 1992 |
|
RU2125980C1 |
| INDANE, DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND METHOD OF ANTOGONIZATION OF ENDOTHELINE RECEPTORS | 1994 |
|
RU2130920C1 |
